Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul:82:162-175.
doi: 10.1016/j.semcancer.2021.02.014. Epub 2021 Feb 25.

Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors

Adam Lauko  1 , Alice Lo  2 , Manmeet S Ahluwalia  3 , Justin D Lathia  4
Affiliations
Review

Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors

Adam Lauko et al. Semin Cancer Biol. 2022 Jul.

Abstract

Brain tumors remain one of the most difficult tumors to treat and, depending on the diagnosis, have a poor prognosis. Of brain tumors, glioblastoma (GBM) is the most common malignant glioma and has a dismal prognosis, with only about 5% of patients alive five years after diagnosis. While advances in targeted therapies and immunotherapies are rapidly improving outcomes in a variety of other cancers, the standard of care for GBM has largely remained unaltered since 2005. There are many well-studied challenges that are either unique to brain tumors (i.e., blood-brain barrier and immunosuppressive environment) or amplified within GBM (i.e., tumor heterogeneity at the cellular and molecular levels, plasticity, and cancer stem cells) that make this disease particularly difficult to treat. While we touch on all these concepts, the focus of this review is to discuss the immense inter- and intra-tumoral heterogeneity and advances in our understanding of tumor cell plasticity and epigenetics in GBM. With each improvement in technology, our understanding of the complexity of tumoral heterogeneity and plasticity improves and we gain more clarity on the causes underlying previous therapeutic failures. However, these advances are unlocking new therapeutic opportunities that scientists and physicians are currently exploiting and have the potential for new breakthroughs.

Keywords: Epigenetics; Glioblastoma; Heterogeneity; Plasticity; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Manmeet Ahluwalia declares the following: grants/research support-Astrazeneca, Abbvie, BMS, Bayer, Incyte, Pharmacyclics, Novocure, Mimivax, Merck. Receipt of honoraria or consulting fees: Elsevier, Wiley, VBI, Vaccines, Bayer, Tocagen, Novocure. Shareholder: Doctible, Mimivax, Cytodyn.

Figures

Figure 1.
Figure 1.. Glioblastoma exhibits inter- and intratumoral heterogeneity at multiple levels.
Schematic depicting inter- and intratumoral heterogeneity ranging from epigenetic changes to the enhancer landscape to amplification of receptor tyrosine kinases.
Figure 2.
Figure 2.. The tumor microenvironment of glioblastoma includes various other cells types in addition to tumor cells.
Schematic depicting the crosstalk between cell types in the tumor microenvironment that drive glioblastoma progression and recurrence.
See this image and copyright information in PMC

References

    1. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK, Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival, J Natl Cancer Inst. 109 (2017). 10.1093/jnci/djx030. - DOI - PMC - PubMed
    1. Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A, Recent Trends in Epidemiology of Brain Metastases: An Overview, Anticancer Res. 32 (2012) 4655–4662. - PubMed
    1. Hall WA, Djalilian HR, Nussbaum ES, Cho KH, Long-term survival with metastatic cancer to the brain, Med. Oncol 17 (2000) 279–286. - PubMed
    1. Percy AK, Elveback LR, Okazaki H, Kurland LT, Neoplasms of the central nervous system. Epidemiologic considerations, Neurology. 22 (1972) 40–48. 10.1212/wnl.22.1.40. - DOI - PubMed
    1. Tsukada Y, Fouad A, Pickren JW, Lane WW, Central nervous system metastasis from breast carcinoma. Autopsy study, Cancer. 52 (1983) 2349–2354. - PubMed

Publication types